-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
【Chemical machinery equipment network market analysis ] China has becomeA major producer of pharmaceutical equipment , with a wide range of products, complete varieties and specifications, product technology has also developed from simple imitation to cooperative development and independent innovation research and development stages.
While meeting the basic construction, technological transformation, and equipment renewal of thousands of domestic pharmaceutical companies, it has also gradually upgraded its products.
Promote to overseas markets and contribute more to the development of *healthy business.
In recent years, with the rapid development of the pharmaceutical industry, the scale of my country's pharmaceutical equipment industry has continued to grow.
As of December 2020, the market size of the pharmaceutical machinery industry has approached 50 billion yuan.
Market analysis of chemical machinery equipment networkChemical machinery and equipmentPharmaceutical equipmentWhile meeting the basic construction, technological transformation, and equipment renewal of thousands of domestic pharmaceutical companies, it has also gradually upgraded its products.
Promote to overseas markets and contribute more to the development of *healthy business.
In recent years, with the rapid development of the pharmaceutical industry, the scale of my country's pharmaceutical equipment industry has continued to grow.
As of December 2020, the market size of the pharmaceutical machinery industry has approached 50 billion yuan.
The "2020 Edition of China's Pharmaceutical Equipment Market Status Survey and Development Trend Analysis Report" released by China Industry Research Network believes that the investment prospects of China's pharmaceutical machinery industry are very broad, and the pharmaceutical machinery industry has a clear trend of replacing imports in the future.
Data show that in 2016, about 30% of my country’s pharmaceutical equipment market relied on imports, and most of the imported products were gas phaseChromatographs and other products with special requirements such as scientific research, but for general teaching purposes and requirements, pharmaceutical companies often choose domestic equipment.
ChromatographIn recent years, with the continuous development of pharmaceutical technology and equipment, the substitution of domestic imports has accelerated.
At present, the low-end areas of my country's pharmaceutical machinery industry have basically achieved localization, and domestic-funded enterprises in the mid-* field are gradually replacing imports with some comparative advantages, and are expected to step out of* and join the market competition.
At present, the low-end areas of my country's pharmaceutical machinery industry have basically achieved localization, and domestic-funded enterprises in the mid-* field are gradually replacing imports with some comparative advantages, and are expected to step out of* and join the market competition.
First, the cost is lower.
In the traditional Chinese medicine machine market, pharmaceutical companies basically rely on imports, so the price is very expensive.
Take liquid chromatographs and other detection equipment as an example.
Such equipment often costs millions of yuan, which is a heavy burden for most pharmaceutical companies.
Compared with imported equipment, the cost of domestically produced pharmaceutical machines is often lower.
It is understood that, generally speaking, domestically produced equipment can be about half cheaper than imported ones.
Therefore, the domestic drug machine is expected to win the market with the advantages of affordable and cost-effective.
The industry believes that this market chain is difficult to be destroyed once it is formed.
Although the number and competitiveness of domestically-made pharmaceutical machinery manufacturers in the Chinese market is still insufficient, it can be seen that many domestic companies are aiming at the market and continue to exert strength.
This trend will continue to grow, and it is expected to accelerate the substitution of imported products in the future.
In the traditional Chinese medicine machine market, pharmaceutical companies basically rely on imports, so the price is very expensive.
Take liquid chromatographs and other detection equipment as an example.
Such equipment often costs millions of yuan, which is a heavy burden for most pharmaceutical companies.
Compared with imported equipment, the cost of domestically produced pharmaceutical machines is often lower.
It is understood that, generally speaking, domestically produced equipment can be about half cheaper than imported ones.
Therefore, the domestic drug machine is expected to win the market with the advantages of affordable and cost-effective.
The industry believes that this market chain is difficult to be destroyed once it is formed.
Although the number and competitiveness of domestically-made pharmaceutical machinery manufacturers in the Chinese market is still insufficient, it can be seen that many domestic companies are aiming at the market and continue to exert strength.
This trend will continue to grow, and it is expected to accelerate the substitution of imported products in the future.
Second, the channels are more complete.
After years of intensive development, domestic-funded pharmaceutical machinery companies often have relatively comprehensive channel advantages in the local area, and are expected to continue to open the market in different regions.
With the gradual transformation of domestic pharmaceutical equipment from the low-end to the low-end, the industry threshold will also gradually increase.
The industry expects that the industry's internal channel-side competition will become more intense in the future.
After years of intensive development, domestic-funded pharmaceutical machinery companies often have relatively comprehensive channel advantages in the local area, and are expected to continue to open the market in different regions.
With the gradual transformation of domestic pharmaceutical equipment from the low-end to the low-end, the industry threshold will also gradually increase.
The industry expects that the industry's internal channel-side competition will become more intense in the future.
Third, the service is better.
Service is also one of the core competitiveness of pharmaceutical machinery companies, involving pre-sales and after-sales services.
In recent years, domestic pharmaceutical companies have paid more attention to services and established their own service systems.
Many companies have transformed from providing a single product to providing overall service solutions to enhance customer stickiness and provide continuous product and follow-up services.
Provide strong support.
Service is also one of the core competitiveness of pharmaceutical machinery companies, involving pre-sales and after-sales services.
In recent years, domestic pharmaceutical companies have paid more attention to services and established their own service systems.
Many companies have transformed from providing a single product to providing overall service solutions to enhance customer stickiness and provide continuous product and follow-up services.
Provide strong support.
Relying on the above-mentioned advantages, domestic pharmaceutical machinery companies are full of confidence in the process of entering the * market.
For example, some companies have focused on the monoclonal antibody industry that has developed vigorously in the past two years.
In view of the current situation where almost all equipment used in the industry depends on imports, the company stated that its goal is to use domestically produced products in 5-10 years.
Equipment to replace imported products.
For example, some companies have focused on the monoclonal antibody industry that has developed vigorously in the past two years.
In view of the current situation where almost all equipment used in the industry depends on imports, the company stated that its goal is to use domestically produced products in 5-10 years.
Equipment to replace imported products.
It is worth mentioning that some pharmaceutical robots pointed out that product performance, market share, and user acceptance all determine whether users can purchase the company's products.
But at present, there are still some gaps in the performance of domestically produced pharmaceutical machinery compared with imported products, and due to the low concentration of the domestic pharmaceutical equipment industry, the influence of the brand is relatively lacking, so how to improve the brand influence of domestic pharmaceutical machinery products It is a problem that enterprises in the industry need to work hard to solve.
But at present, there are still some gaps in the performance of domestically produced pharmaceutical machinery compared with imported products, and due to the low concentration of the domestic pharmaceutical equipment industry, the influence of the brand is relatively lacking, so how to improve the brand influence of domestic pharmaceutical machinery products It is a problem that enterprises in the industry need to work hard to solve.
Original title: China's pharmaceutical machinery industry has broad investment prospects, and the future trend of replacing imports is obvious
